CIENCE CIENCEa graph8 company
+ New search
Your company
24 companies like Scribe Therapeutics
Scribe Therapeutics logo

Scribe Therapeutics

scribetx.com
Scribe Therapeutics is a CRISPR-based genetic medicine company founded in 2017 by Nobel laureate Jennifer A. Doudna and CRISPR pioneer Benjamin L. Oakes, developing molecularly engineered CRISPR therapeutics — including the clinical-stage epigenetic silencing therapy STX-1150 — to treat cardiometabolic disease and other conditions.
RHBOTIKCJWKHESDT
201751-200 emp
1150 Marina Vlg Pkwy, Alameda, California
$50 Million to 100 Million revenue
Biotechnology Research
NAICS 541714
1312•••••55
TECH STACK
CloudflareWebflow
Scribe Therapeutics campaignconsultative3000 target
Companies like Scribe Therapeutics — Biotechnology Research, 51-200
“Scribe is engineering CRISPR medicines precisely — not taking shortcuts — to make genetic treatment safe and effective enough for everyone.”
Launch outbound on autopilot

Personalised emails written for every contact · 97% deliverability · live in 60 seconds

Companies 22
Decision-makers 19
Emails 19
Signals 0

Companies like Scribe Therapeutics — competitors and alternatives

CompanyWhat they doLocationSizeHiring
Scribe Therapeuticsscribetx.com
RHBOTI
Scribe Therapeutics is a CRISPR-based genetic medicine company founded in 2017 by Nobel laureate Jennifer A. Doudna and CRISPR pioAlameda, California51-200
CRISPR Therapeuticscrisprtx.com
SGGWHX
CRISPR Therapeutics is a gene-editing biotechnology company pioneering CRISPR-based medicines, with CASGEVY™ — the first-ever apprBoston, Massachusetts201-1000
Intelliaintellia.com
MammothBiomammothbio.com
MammothBio is a Chicago-based research services company founded in 2014 that provides medical and biological image post-processingChicago, Illinois
Vervetherapeuticsvervetherapeutics.com
Precisionbiosciencesprecisionbiosciences.com
AKASCA
Precision BioSciences (Nasdaq: DTIL) is a clinical-stage gene editing company based in Durham, North Carolina, developing in vivo Durham, North Carolina51-200
Crisprtherapeuticscrisprtherapeutics.com
Egenesisegenesis.com
Caribou Biosciencescariboubio.com
PMZASM
Caribou Biosciences is a clinical-stage biopharmaceutical company developing off-the-shelf, allogeneic CAR-T cell therapies using Berkeley, California51-200
APGPHP
Scribe is an AI-powered workflow documentation platform that automatically captures step-by-step guides of how teams actually workSan Francisco, California201-1000
Allogene Therapeuticsallogene.com
SKSMSC
Allogene Therapeutics is a clinical-stage biotechnology company developing investigational allogeneic chimeric antigen receptor T South San Francisco, California201-1000
Graphite Biographitebio.com
AL
Graphite Bio is a clinical-stage, next-generation gene editing company based in South San Francisco, California, pioneering the UlSouth San Francisco, California1-10
Logicbiologicbio.com
Beam Therapeuticsbeamtx.com
Beam Therapeutics is a CRISPR base editing biotechnology company founded in 2017 and headquartered in Cambridge, MA, developing a Cambridge, Massachusetts201-1000
Intelliatxintelliatx.com
Intellia Therapeutics is a clinical-stage biopharmaceutical company developing CRISPR-based gene editing therapies to treat severeCambridge, Massachusetts201-1000
Genetix Biotherapeutics (formerly bluebird bio) is a privately held, Boston-area gene therapy company developing first-in-class, oSeattle, Washington1-10
REGENXBIOregenxbio.com
REGENXBIO is a clinical-stage biotechnology company founded in 2008 and headquartered in Rockville, Maryland, pioneering AAV gene Rockville, Maryland201-1000
Homologymedicinehomologymedicine.com
Cariboubiosciencescariboubiosciences.com
Editas Medicineeditasmedicine.com
Editas Medicine is a clinical-stage genome editing company that develops CRISPR-based medicines for serious diseases, with a pipelCambridge, Massachusetts51-200
Run live for more

Agent activity

Done
$fetch_profilescribetx.com
Found: Scribe Therapeutics
$analyze_identityscribetx.com
Scribe Therapeutics is a CRISPR-based genetic medicine company founded in 2017 by Nobel laureate Jennifer A. Doudna and CRISPR pioneer Benjamin L. Oakes, developing molecularly eng
$search_companiescompanies like Scribe Therapeutics
24 companies
$search_peopledecision-makers

Frequently asked questions about Scribe Therapeutics

What does Scribe Therapeutics do?

Scribe Therapeutics is a CRISPR-based genetic medicine company founded in 2017 by Nobel laureate Jennifer A. Doudna and CRISPR pioneer Benjamin L. Oakes, developing molecularly engineered CRISPR therapeutics — including the clinical-stage epigenetic silencing therapy STX-1150 — to treat cardiometabolic disease and other conditions.

Who are Scribe Therapeutics's competitors?

Companies like Scribe Therapeutics include CRISPR Therapeutics, Intellia, Editas, MammothBio, Vervetherapeutics. See the full list of 24 competitors and alternatives above.

How many employees does Scribe Therapeutics have?

Scribe Therapeutics has approximately 51-200 employees and is in the Biotechnology Research industry.

Where is Scribe Therapeutics headquartered?

Scribe Therapeutics is headquartered in Alameda, California.

What industry is Scribe Therapeutics in?

Scribe Therapeutics operates in the Biotechnology Research industry.

Who are the decision-makers at Scribe Therapeutics?

Key decision-makers and buying contacts at Scribe Therapeutics are listed above, including leaders across executive, finance, sales and operations.